terns detected with localized H-1 MR spectroscopy. Radiology，1992，183： 701-709.       10   Hakumaki JM， Poptani H， Sandmair A-M，et al.1H MRS detects polyunsaturated fatty acid accumulation during gene therapy of glioma： implications for the in vivo detection of apoptosis. Nat Med，1999，5：1323-1327.       11   Sijens PE， Oudkerk M，Van Dijk P，et al.1H MR spectroscopy monitoring of changes in choline peak area and line shape after Gd-contrast administration. Magn Reson Imag，1998，16： 1273-1280.       12   Lin AP，Ross BD. Short-echo time proton MR spectroscopy in the presence of gadolinium. J Comput Assist Tomogr，2001，25： 705-712.       13   Majos C， Alonso J， Aguilera C，et al. Adult primitive neuroectodermal tumor： proton MR spectroscopic findings with possible applications for differential diagnosis. Radiology，2002，225： 556-566.      14   McKnight TR， Noworolski SM， Vigneron DB，et al. An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma. J Magn Reson Imag，2001，13：167-177.       15   Wilken B， Dechent P， Herms J，et al. Quantitative proton magnetic resonance spectroscopy of focal brain lesions. Pediatr Neurol，2000，23： 22-31.       16   Krouwer HGJ， Kim TA， Rand SD，et al. Singel-voxel proton MR spectroscopy of nonneoplastic brain lesions suggestive of a neoplasm. Am J Neuroradiol，1998，19： 1695-1703.       17   Saunders DE， Howe FA， Van Den Boogaart A，et al. Proton spectroscopy in acute and chronic stroke. Stroke，1995，26：1007-1013.       18   Davie CA， Hawkins CP， Barker GJ，et al. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions. Brain，1994，117： 49-58.       19   Graves EE， Nelson SJ， Vigneron DB，et al. Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. Am J Neuroradiol，2001，22： 613-624.       20   Antiniw AS， Lau A， Nelson SJ. 1H magnetic resonance spectroscopic imaging as a tool for evaluating patients with recurrent gliomas begin considered for treatment with gamma knife radiosurgery. In： Proceedings of the 10th Annual Meeting of ISMRM， Honolulu， Hawai’i， USA， 2002，574.       21   Moller-Hartmann W， Herminghaus S， Krings T，et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology，2002，44：371-378.       22   Rabinov JD， Lee PL， Barker FG， et al. In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects： initial experience. Radiology，2002，225： 871-879.       23   Rickman DS， Bobek MP， Misek DE，et al. Distinctive molecular profiles of highgrade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res，2001，61： 6885-6891.

上一页  [1] [2] [3]